We became interested in Moesin as a candidate mediator of actin over-stabilization and cell cycle activation based on its presence as a WGCNA hub gene in co-expression networks of both human Alzheimer’s disease and tau transgenic mice, its known role as a mediator of cancer and the EMT, and its ability to regulate actin. The gene discussed is MAPT; the disease is cancer.